Top Story

One-third of patients do not receive recommended post-mastectomy radiation

March 3, 2015

Only 65% of women with breast cancer whose disease spread to four or more nearby lymph nodes underwent recommended radiation therapy after mastectomy, according to study results.

“My colleagues and I were quite startled by the finding that a third of patients with N2/N3 disease did not receive post-mastectomy radiation therapy, which is the standard of care,” Quyen D. Chu, MD, MBA, FACS, professor of surgery at Louisiana State University Health Sciences Center, said in a press release. “From this study, we could not tease out whether patients refuse treatment or there is a lack of awareness among women and physicians about the need for radiation therapy after mastectomy for locally advanced breast cancer. If women with N2/N3 breast cancer who plan a mastectomy are not offered post-mastectomy radiation therapy, they should ask their physician why.”

In the Journals

Reduced ischemia time may decrease HCC recurrence after liver transplant

March 3, 2015
Reduced cold and warm ischemia times could decrease the risk for hepatocellular carcinoma recurrence after liver transplantation, according to data published in…
FDA NewsDrug Pipeline

FDA grants orphan drug designation to Reolysin for peritoneal cancer

March 3, 2015
The FDA today granted orphan drug designation to pelareorep for the treatment of peritoneal cancer, according to a press release from the drug’s…
Sebastiano Filleti In the Journals

Most benign thyroid nodules remain benign during follow-up

March 3, 2015
A majority of asymptomatic, benign thyroid nodules had no significant change in size after 5 years of follow-up, according to study findings published in JAMA. Thyroid…

Study: No benefit from anticoagulant use in Behçet’s disease

March 3, 2015
Patients with vascular manifestations of Behçet’s disease who received treatment with anticoagulants did not benefit from the therapy given in addition to…
More News Headlines »
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »
thumbnail for video 4040847621001

MET targeting, PD-L1/PD-1 inhibition highlight recent developments in genitourinary oncology

February 11, 2015
Derek Raghavan, MD, PhD, FACP, FRACP, FASCO, president of Levine Cancer Institute at Carolinas HealthCare System and…
More »
Hot melanoma

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates - Monograph

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »